1Beno?t P. Guery,Maiken C. Arendrup,Georg Auzinger,élie Azoulay,Márcio Borges Sá,Elizabeth M. Johnson,Eckhard Müller,Christian Putensen,Coleman Rotstein,Gabriele Sganga,Mario Venditti,Rafael Zaragoza Crespo,Bart Jan Kullberg.Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis[J].Intensive Care Medicine.2009(1)
2Moragues MD,Oritiz N,Iruretagoyena JR,et al.Evaluation ofa new commercial test (Candida albicansIFAIgG)for the se-rodiagnosis of invasive candidiasis[].Enferm Infecc MicrobiolClin.2004
3Pazos C,Moragues MD,Quindos G,et al.Diagnosis potentiallof (1,3)-beta-D-G\glucan and anti-Candida albicansgermtube antibodyies for the diagnosis and therapeutic monitoring ofinvasive candidiasis in neutronpenic adult patients[].Rev Ibe-roam Micol.2006
4Clancy CJ,Nguyen ML,Cheng S,et al.Immunoglobulin G re-sponses to a panel ofCandidia albicansantigens as accurate andearly markers for the presence of systemic candidiasis[].Journal of Clinical Microbiology.2008
5Kontoyiannis DP,Reddy BT,Torres HA,et al.Pulmonary can-didiasis in patients with cancer:an autopsy study[].Clinical Infectious Diseases.2002
6Ruping MJ,Vehreschild JJ,Cornely OA.Patienta at high risk ofinvasive fungal infections:when and how to treat[].Drugs.2008
7Hobson,RP.The global epidemiology of invasive Candida infections—is the tide turning[].Journal of Hospital Infection.2003
8N. Kondori,L. Edebo,I. Mattsby-Baltzer.Circulating beta (1–3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis[].Clinical and Diagnostic Laboratory Immunology.2004
9Guery BP,Arendrup MC,Auzinger G, et al.Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part Ⅰ. Epidemiology and diagnosis[].Intensive Care Medicine.2009
10Staab,JF,Sundstrom,P.Genetic organization and sequence analysis of the hypha-specific cell wall protein gene HWP1 of Candida albicans[].Yeast.1998
